In 1987, Mohan Singh had turned down the proposal of Parvinder Singh, of setting up a similar plant as that of Max India (built by Mohan Singh for his younger son Analjit) for making the 6APA compound. That was the beginning of the end of the father-son relationship! The milieu became worse in the early 1990s, when Parvinder differed from Mohan in his attempts to make Ranbaxy a global corporation. The saga of Parvinder Singh becoming the patriarch and his split with the founder became more lucid in the boardroom battle of 1993, and Mohan Singh was ousted from Ranbaxy, thereby appointing younger son Analjit as the sole legal representative for his 2.4 million shares in the company. With Mohan Singh’s death, a legal tussle started between Analjit and his nephews Malvinder and Shivender – sons of Parvinder Singh – the latter duo claiming that their late father had owned the shares directly.
For Complete IIPM - Article, Click on IIPM-Editorial Link
Source:- IIPM-Business and Economy, Editor:- Prof. Arindam Chaudhuri - 2006
For Complete IIPM - Article, Click on IIPM-Editorial Link
Source:- IIPM-Business and Economy, Editor:- Prof. Arindam Chaudhuri - 2006
No comments:
Post a Comment